Cutaneous vasculature systems play a role in regulating skin pigmentation. We analysed RNA sequencing data to identify novel antimelanogenic factors secreted from endothelial cells and found that one of the secreted factors, clusterin, is highly expressed by HDMECs.
| QUESTION ADDRESSED
In this study, we analysed RNA sequencing data to identify novel antimelanogenic factors secreted from endothelial cells. There is a high level of the expression of the clusterin gene in HDMECs. Because clusterin is known to be an extremely sensitive biosensor of oxidative stress and inflammation in human tissues [9, 10] , and given that clusterin signalling reportedly has regulatory effects on melanoma growth [11] , this result was of interest. We therefore investigated the expression of clusterin in HDMECs in the skin and the in vitro effect of HDMEC-derived clusterin on pigmentation.
| EXPERIMENTAL DESIGN
The endogenous expression of clusterin in endothelial cells was in- 
| RESULTS
HDMECs highly expressed clusterin ( Figure 1A ). As previously shown [8] Figure 1C ). It has been reported that dermal fibroblasts also express clusterin [12, 13] . We found that the RNA expression levels of clusterin were 3.39-fold higher and that the secreted amount in the conditioned medium was 12.6-fold higher than that of fibroblasts ( Figure 1C 
| CONCLUSION
In this study, we demonstrated that HDMECs secrete copious amounts of clusterin and that clusterin is a major factor contributing the inhibitory effect of endothelial cells on melanogenesis. Melanocytes reduced the expression of tyrosinase through the down-expression of MITF responding to the HDMEC-derived clusterin. The in vivo biological role of clusterin is presently unclear; however, it is likely that in a physiologic situation, cutaneous vascular endothelial cells secrete clusterin as well as TGFβ1 and play a role in maintaining low levels of pigment production [8] . Clusterin is also secreted from skin fibroblasts [12, 13] , and very recently, we found an inhibitory role of fibroblastderived clusterin on pigmentation [13] . In this study, we also found that
HDMECs are the major cells secreting clusterin at levels much higher than those of fibroblasts. All of these findings suggest paracrine crosstalk between endothelial cells and melanocytes through clusterin to inhibit pigmentation.
We previously reported that TGFβ1 is one of the secreted factors through which endothelial cells inhibit pigmentation [8] .
Interestingly, a relationship between clusterin and TGFβ1 signalling has been reported, and clusterin works via the TGFβ1 receptor-Smad pathway [14] . We found that recombinant clusterin itself increased Smad2 phosphorylation in melanocytes (Fig. S2A) . Furthermore, clusterin regulates PAX3 expression, which is a well-known target gene of TGFβ1 signalling [15] and a transcription factor of MITF [16] (Fig. S2B and C) . All of these results suggest that clusterin functions via the TGFβ receptor-Smad pathway in melanocytes. It has been reported that a combination of clusterin and TGFβ1 augments Smad signalling [14] ; therefore, it is likely that endothelial cell-derived clusterin and TGFβ1 act on pigmentation synergically.
The inhibitory action of clusterin to control pigmentation further suggests clusterin as a possible therapeutic target for the development of skin-lightening agents for hyperpigmentation. 
